Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 110

Similar articles for PubMed (Select 22307401)

1.

Improved closure of patent ductus arteriosus with high doses of ibuprofen.

Meißner U, Chakrabarty R, Topf HG, Rascher W, Schroth M.

Pediatr Cardiol. 2012 Apr;33(4):586-90. doi: 10.1007/s00246-012-0182-2. Epub 2012 Feb 4.

PMID:
22307401
2.

A comparison of oral ibuprofen and intravenous indomethacin for closure of patent ductus arteriosus in preterm infants.

Chotigeat U, Jirapapa K, Layangkool T.

J Med Assoc Thai. 2003 Aug;86 Suppl 3:S563-9.

PMID:
14700149
3.

The fate of ductus arteriosus in infants at 23-27 weeks of gestation: from spontaneous closure to ibuprofen resistance.

Dani C, Bertini G, Corsini I, Elia S, Vangi V, Pratesi S, Rubaltelli FF.

Acta Paediatr. 2008 Sep;97(9):1176-80. doi: 10.1111/j.1651-2227.2008.00871.x.

PMID:
18624987
4.

Closure of patent ductus arteriosus with oral ibuprofen suspension in premature newborns: a pilot study.

Heyman E, Morag I, Batash D, Keidar R, Baram S, Berkovitch M.

Pediatrics. 2003 Nov;112(5):e354.

PMID:
14595076
5.

Comparison of ibuprofen and indometacin for early-targeted treatment of patent ductus arteriosus in extremely premature infants: a randomised controlled trial.

Su BH, Lin HC, Chiu HY, Hsieh HY, Chen HH, Tsai YC.

Arch Dis Child Fetal Neonatal Ed. 2008 Mar;93(2):F94-9. Epub 2007 Sep 3.

PMID:
17768157
6.

An optimized ibuprofen dosing scheme for preterm neonates with patent ductus arteriosus, based on a population pharmacokinetic and pharmacodynamic study.

Hirt D, Van Overmeire B, Treluyer JM, Langhendries JP, Marguglio A, Eisinger MJ, Schepens P, Urien S.

Br J Clin Pharmacol. 2008 May;65(5):629-36. doi: 10.1111/j.1365-2125.2008.03118.x. Epub 2008 Feb 27.

7.

Oral versus intravenous ibuprofen for patent ductus arteriosus closure: a randomised controlled trial in extremely low birthweight infants.

Erdeve O, Yurttutan S, Altug N, Ozdemir R, Gokmen T, Dilmen U, Oguz SS, Uras N.

Arch Dis Child Fetal Neonatal Ed. 2012 Jul;97(4):F279-83. doi: 10.1136/archdischild-2011-300532. Epub 2011 Dec 5.

PMID:
22147286
8.

Comparison of ibuprofen and indomethacin therapy for patent ductus arteriosus in preterm infants.

Su PH, Chen JY, Su CM, Huang TC, Lee HS.

Pediatr Int. 2003 Dec;45(6):665-70.

PMID:
14651538
9.

Randomized pilot study comparing oral ibuprofen with intravenous ibuprofen in very low birth weight infants with patent ductus arteriosus.

Cherif A, Khrouf N, Jabnoun S, Mokrani C, Amara MB, Guellouze N, Kacem S.

Pediatrics. 2008 Dec;122(6):e1256-61. doi: 10.1542/peds.2008-1780.

PMID:
19047225
10.

Repeated courses of ibuprofen are effective in closure of a patent ductus arteriosus.

van der Lugt NM, Lopriore E, Bökenkamp R, Smits-Wintjens VE, Steggerda SJ, Walther FJ.

Eur J Pediatr. 2012 Nov;171(11):1673-7. doi: 10.1007/s00431-012-1805-6. Epub 2012 Aug 5.

PMID:
22864766
11.

Comparison of oral ibuprofen with oral indomethacin for PDA closure in Indian preterm neonates: a randomized controlled trial.

Yadav S, Agarwal S, Maria A, Dudeja A, Dubey NK, Anand P, Yadav DK.

Pediatr Cardiol. 2014 Jun;35(5):824-30. doi: 10.1007/s00246-014-0861-2. Epub 2014 Jan 17.

PMID:
24435507
12.

Dose-finding study of ibuprofen in patent ductus arteriosus using the continual reassessment method.

Desfrere L, Zohar S, Morville P, Brunhes A, Chevret S, Pons G, Moriette G, Rey E, Treluyer JM.

J Clin Pharm Ther. 2005 Apr;30(2):121-32.

PMID:
15811164
13.

Timing of patent ductus arteriosus treatment and respiratory outcome in premature infants: a double-blind randomized controlled trial.

Sosenko IR, Fajardo MF, Claure N, Bancalari E.

J Pediatr. 2012 Jun;160(6):929-35.e1. doi: 10.1016/j.jpeds.2011.12.031. Epub 2012 Jan 28.

PMID:
22284563
14.

Comparison of oral Ibuprofen and intravenous indomethacin for the treatment of patent ductus arteriosus in extremely low birth weight infants.

Yang EM, Song ES, Choi YY.

J Pediatr (Rio J). 2013 Jan-Feb;89(1):33-9. doi: 10.1016/j.jped.2013.02.006.

15.

Oral ibuprofen in early curative closure of patent ductus arteriosus in very premature infants.

Cherif A, Jabnoun S, Khrouf N.

Am J Perinatol. 2007 Jun;24(6):339-45. Epub 2007 Jun 12.

PMID:
17564958
16.

Comparison of oral and intravenous Ibuprofen for medical closure of patent ductus arteriosus: which one is better?

Olukman O, Calkavur S, Ercan G, Atlihan F, Oner T, Tavli V, Kultursay N.

Congenit Heart Dis. 2012 Nov-Dec;7(6):534-43. doi: 10.1111/j.1747-0803.2012.00668.x. Epub 2012 May 22.

PMID:
22613269
17.

Oral ibuprofen versus intravenous ibuprofen or intravenous indomethacin for the treatment of patent ductus arteriosus in preterm infants: a systematic review and meta-analysis.

Neumann R, Schulzke SM, Bührer C.

Neonatology. 2012;102(1):9-15. doi: 10.1159/000335332. Epub 2012 Mar 8. Review.

PMID:
22414850
18.

Oral ibuprofen and indomethacin for treatment of patent ductus arteriosus in premature infants: a randomized trial at Ramathibodi Hospital.

Supapannachart S, Limrungsikul A, Khowsathit P.

J Med Assoc Thai. 2002 Nov;85 Suppl 4:S1252-8.

PMID:
12549803
19.

Ibuprofen lysinate and sodium ibuprofen for prophylaxis of patent ductus arteriosus in preterm neonates.

De Carolis MP, Bersani I, De Rosa G, Cota F, Romagnoli C.

Indian Pediatr. 2012 Jan;49(1):47-9. Epub 2011 Aug 15.

PMID:
21992864
20.

Efficacy and safety of oral versus intravenous ibuprofen in very low birth weight preterm infants with patent ductus arteriosus.

Gokmen T, Erdeve O, Altug N, Oguz SS, Uras N, Dilmen U.

J Pediatr. 2011 Apr;158(4):549-554.e1. doi: 10.1016/j.jpeds.2010.10.008. Epub 2010 Nov 20. Erratum in: J Pediatr. 2012 Jan;160(1):181.

PMID:
21094951
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk